赛隆药业(002898) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥56,393,778.01, representing a 46.83% increase compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2021 was ¥2,385,142.21, a significant increase of 128.54% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥208,440.63, up 102.32% from the previous year[3]. - The basic earnings per share for Q3 2021 was ¥0.0136, an increase of 128.63% compared to the same period last year[3]. - Total operating revenue for Q3 2021 reached ¥185,425,358.96, a significant increase of 46.2% compared to ¥126,844,155.03 in the same period last year[22]. - Operating profit for Q3 2021 was ¥16,239,882.45, recovering from a loss of ¥19,968,942.95 in Q3 2020[22]. - Net profit for Q3 2021 was ¥11,800,954.52, compared to a net loss of ¥21,568,786.50 in the previous year, marking a turnaround[23]. - Basic and diluted earnings per share for Q3 2021 were both ¥0.0671, compared to a loss per share of ¥0.1225 in Q3 2020[24]. Assets and Liabilities - The total assets at the end of Q3 2021 reached ¥860,468,633.69, reflecting a 5.71% increase from the end of the previous year[3]. - Total current assets amounted to ¥280,995,034.42, compared to ¥242,891,326.49 in the previous year, reflecting a growth of 15.7%[18]. - Total assets reached ¥860,468,633.69, an increase from ¥813,959,860.22, showing a growth of 5.7%[18]. - Total liabilities increased to ¥261,665,237.97 from ¥226,957,419.02 year-over-year, reflecting a growth of 15.3%[22]. - Total liabilities include accounts payable of ¥58,383,636.55, down from ¥64,501,377.17, a decrease of 9.3%[18]. - The total assets of the company as of Q3 2021 amounted to ¥813,959,860.22, with total liabilities at ¥226,957,419.02, indicating a healthy asset-liability ratio[30]. Cash Flow - The company's cash flow from operating activities for the year-to-date period was ¥3,934,504.24, showing a 129.76% increase[3]. - Cash inflow from operating activities was ¥173,105,200.23, compared to ¥143,538,568.07 in the same period last year, representing a growth of 20.6%[25]. - The net cash flow from operating activities for Q3 2021 was ¥3,934,504.24, a significant improvement compared to a net outflow of ¥13,222,283.85 in Q3 2020, indicating a turnaround in operational efficiency[26]. - Total cash inflow from financing activities was ¥123,400,000.00, while cash outflow was ¥86,731,707.48, resulting in a net cash flow of ¥36,668,292.52 for the quarter[26]. - The company reported a total cash and cash equivalents balance of ¥87,535,935.17 at the end of Q3 2021, up from ¥57,797,604.85 at the beginning of the quarter, reflecting a net increase of ¥29,738,330.32[26]. - Investment activities resulted in a net cash outflow of ¥10,864,466.44, compared to a larger outflow of ¥53,975,236.80 in the same period last year, showing improved capital management[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,673[14]. - The company has a significant shareholder, Cai Nanguai, holding 51.15% of shares, with 28,000,000 shares pledged[14]. - Total equity attributable to shareholders reached ¥598,803,395.72, up from ¥587,002,441.20, indicating a growth of 2.9%[22]. - The company’s total equity stood at ¥587,002,441.20, reflecting stability in shareholder value amidst operational changes[30]. Research and Development - The company is actively involved in research and development, with development expenditures increasing to ¥31,079,580.05 from ¥23,495,565.52, a growth of 32.3%[18]. - Research and development expenses for Q3 2021 were ¥14,988,989.35, slightly down from ¥16,231,580.53 in Q3 2020[22]. Borrowings - The company’s long-term borrowings increased by 67.27% to ¥47,270,000.00, primarily due to new bank loans[10]. - Short-term borrowings increased to ¥110,000,000.00 from ¥90,000,000.00, marking a rise of 22.2%[18]. - The company’s short-term borrowings remained stable at ¥90,000,000.00, indicating a consistent approach to managing short-term financing needs[30]. Other Information - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[15]. - The company executed a new leasing standard starting January 1, 2021, which required adjustments to the financial statements, impacting the non-current assets and liabilities[27]. - The company did not conduct an audit for the Q3 2021 report, which may affect the perception of financial reliability[31].